Identification of FDA-approved drugs that computationally bind to MDM2

Similar Items

• Identification of Novel Activators of Constitutive Androstane Receptor from FDA-approved Drugs by Integrated Computational and Biological Approaches
  od: Lynch, Caitlin, i dr.
  Izdano: (2012)
• Identification of FDA-approved drugs targeting the Farnesoid X Receptor
  od: van de Wiel, Sandra M. W., i dr.
  Izdano: (2019)
• Identification of FDA-approved oncology drugs with selective potency in high-risk childhood ependymoma.
  od: Donson, Andrew M., i dr.
  Izdano: (2018)
• Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
  od: Van Norman, Gail A.
  Izdano: (2016)
• Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
  od: Jeon, Sangeun, i dr.
  Izdano: (2020)